Quartz 5
Search
Search
Dark mode
Light mode
Explorer
parp-inhibitor
14 items with this tag.
Jul 17, 2026
Olaparib
drug
parp-inhibitor
olaparib
Jul 17, 2026
PARP抑制剂
drug-class
parp-inhibitor
dna-damage-response
Jul 17, 2026
gBRCA1-2与非gBRCA人群的PARP抑制剂证据
comparison
parp-inhibitor
brca
hrd
breast-cancer
Jul 17, 2026
PARP Inhibitors for Breast Cancer Treatment: A Review
group-study
breast-cancer
review
parp-inhibitor
Jul 17, 2026
ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition
group-study
tnbc
znf689
homologous-recombination
parp-inhibitor
pd-l1
Jul 17, 2026
合成致死
concept
synthetic-lethality
dna-repair
parp-inhibitor
Jul 15, 2026
Veliparib
drug
parp-inhibitor
veliparib
Jul 15, 2026
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
group-study
breast-cancer
tnbc
parp-inhibitor
resistance
Jul 15, 2026
P008 组会讲解笔记——乳腺癌 PARP 抑制剂治疗
group-study
presentation
breast-cancer
parp-inhibitor
Jul 15, 2026
P009 组会讲解笔记——FGFR3–PARP1 磷酸化与 PARP 抑制剂耐药
group-study
presentation
breast-cancer
parp-inhibitor
resistance
Jul 15, 2026
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy
group-study
ovarian-cancer
parp-inhibitor
t-cell
car-t
Jul 15, 2026
Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer
group-study
tnbc
mitochondria
gene-therapy
parp-inhibitor
preclinical
Jul 15, 2026
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer (S1416): a randomised, phase 2 trial
group-study
tnbc
metastatic-breast-cancer
parp-inhibitor
cisplatin
randomized-trial
Jul 15, 2026
PARP抑制剂耐药
concept
parp-inhibitor
resistance
dna-repair